Get Free Sample link @ https://www.omrglobal.com/request-sample/opioid-use-disorder-market
High side effects of opioids and the rising frequency of opioid use disorder patients are the major factors that are driving the global opioid use disorder market. According to the Centers for Disease Control and Prevention (CDC), in 2016 in the US, 2.1 million people were suffering from opioid use disorder related to prescribed opioids and 262,000 were suffering from opioid use disorder related to heroin. As per the American Psychiatric Association, in 2017, in the US, over 31,000 people died from an opioid overdose, both prescribed and non-prescribed, among them over 16,000 people died from the overdose of heroin and 15,000 people died from the overdose of prescribes opioids. Sometimes prescribed opioids are more harmful than the non-prescribed opioids. Fentanyl is 100 times more potent than morphine and 50 times more potent than heroin. Such a high prevalence of opioid use disorder is creating demand for OUD drugs to manage the disorder.
A full report of Global Opioid Use Disorder Market available @ https://www.omrglobal.com/industry-reports/opioid-use-disorder-market
• Market Coverage
• Market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered- By Source, By Product Type, By Applications
• Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Global Opioid Use Disorder Market by Segmentation
o By Treatment
o Methadone
o Buprenorphine
o Bunavil
o Suboxone
o Zubsclv
o Sublocade
o Others
o Naltrexone
Regional Analysis
o North America
o United States
o Canada
o Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe
o Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
o Rest of the World
Company Profiles
o Alkermes, PLC.
o BioDelivery Sciences International, Inc.
o Camurus AB
o Hikma Pharmaceuticals PLC
o Indivior PLC
o Mallinckrodt Co.
o Masimo Corp.
o MediciNova, Inc.
o Mylan N.V.
o Novartis AG
o Omeros Corp.
o Orexo US, Inc.
o Teva Pharmaceuticals Industrial, Ltd.
o Titan Pharmaceuticals, Inc.
The Report Covers
• Market value data analysis of 2018 and forecast to 2025.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global opioid use disorder market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/opioid-use-disorder-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404